The statement was written to fill gaps in recommendations from prior consensus statements and guidelines in regards to the use of CCT in cardio-oncology, including use of calcium scoring and ruling out coronary disease when cardiac function is impaired.

Collectors of medical memorabilia may want to plan on preserving the January 2023 print edition of Radiology.

With 91% sensitivity but only 25% specificity, the tool is worthwhile for clinicians who remain wary of frequent false positives that would send patients with no fractures for unneeded imaging.

New data on the Medtronic Intrepid transcatheter mitral valve replacement system from the Intrepid Pilot Study and Intermediate-Term Outcomes of the Intrepid Early Feasibility Study, were presented at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) conference.

A pharmaceutical compound approved 21 years ago to treat breast cancer in postmenopausal women is showing fresh promise as a therapy for glioblastomas. 

The boon comes in the form of greater brain cortical thickness observable on neonatal MRI two weeks after the baby enters the world.

Researchers found that cancer risk in premenopausal women with fatty breasts at initial imaging nearly doubled if an increase in density was observed during their second and third mammograms.

Read our review of some of the biggest FDA-related stories that have hit cardiology in the last month, including news from Viz.ai, Edwards Lifesciences, Abiomed and Medtronic.